Posts With Tag Pharmaceuticals Industry

Discover critical updates in Hepion Pharmaceuticals' Amendment No. 2 to Form 10-K/A, detailing executive compensation errors, stock ownership details, and compliance with Sarbanes-Oxley.

Explore Kiniksa Pharmaceuticals' 8-K filing for January 13, 2025. Discover stock details, financial performance, and essential contact information for investors.